HIV/AIDS

IDSA: Cabotegravir + Rilpivirine Long-Acting ART Beneficial in HIV

Physician’s Briefing

IDSA: Cabotegravir + Rilpivirine Long-Acting ART Beneficial in HIV

18 hours ago

1 min read

High Viral Suppression Found for Patients With HIV Receiving Long-Acting LEN/CAB

Physician’s Briefing

High Viral Suppression Found for Patients With HIV Receiving Long-Acting LEN/CAB

16 Oct 2026

1 min read

Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV

Physician’s Briefing

Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV

05 Aug 2026

2 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com